Alaunos Therapeutics, Inc.·4

Jun 24, 4:31 PM ET

Postma Robert W 4

4 · Alaunos Therapeutics, Inc. · Filed Jun 24, 2022

Insider Transaction Report

Form 4
Period: 2022-06-22
Transactions
  • Award

    Common Stock

    2022-06-22+40,0001,241,870 total
  • Award

    Employee Stock Option (right to buy)

    2022-06-22+100,000100,000 total
    Exercise: $0.82Exp: 2032-06-21Common Stock (100,000 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    4,250,000
  • Common Stock

    (indirect: By Spouse)
    3,574
Footnotes (3)
  • [F1]Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer.
  • [F2]The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
  • [F3]The option vests in twelve equal monthly installments beginning on July 13, 2022.

Documents

2 files